Solara Active Pharma Sciences Limited — Important, 29-04-2025: General Updates

Solara Active Pharma Sciences has incorporated a wholly-owned subsidiary, Synthix Global Pharma Solutions Limited, with an authorized capital of Rs. 15 lac and paid-up capital of Rs. 1 lac. This initiative aligns with the upcoming demerger of their CRAMS and Polymers business into an independent entity. While the subsidiary has not commenced operations, it positions Solara for potential growth in the pharmaceuticals sector, particularly in active pharmaceutical ingredients, enhancing future business prospects.